Conversely, experimental ANGPTL4 knockout in mice improved insulin sensitivity and glucose homeostasis and, indeed, a role of ANGPTL4 antagonist in T2D therapy has been hypothesized [7]. The gene discussed is ANGPTL4; the disease is type 2 diabetes mellitus.